Dr. Noah Appel, M. D.
What this data tells you about Dr. Appel
Dr. Noah Appel is a radiation oncology specialist in Fort Worth, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Appel performed 846 Medicare services across 761 unique beneficiaries.
Between the years covered by Open Payments, Dr. Appel received a total of $6,049 from 33 pharmaceutical and/or device companies across 128 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Appel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 70 | $57 | $292 |
| Ultrasound of both sides of head and neck blood flow | 64 | $30 | $158 |
| Ultrasonic guidance for needle placement | 63 | $24 | $132 |
| Ultrasound study of arm and leg arteries | 50 | $9 | $50 |
| Ultrasonic guidance for blood vessel access | 48 | $11 | $57 |
| Chest X-ray, 1 view | 47 | $7 | $36 |
| Ultrasound of leg arteries or artery grafts | 42 | $29 | $156 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 35 | $10 | $50 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 34 | $14 | $75 |
| Ultrasound of one leg arteries or artery grafts | 34 | $18 | $96 |
| Drainage of fluid from abdominal cavity using imaging guidance | 30 | $80 | $438 |
| Review by radiologist of abscess or sinus cavity study | 29 | $20 | $104 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 29 | $16 | $89 |
| Injection of contrast through abdominal cavity tube for x-ray study | 28 | $27 | $154 |
| Review by radiologist of ct guidance for needle placement | 28 | $56 | $227 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 27 | $26 | $138 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 23 | $37 | $199 |
| Needle biopsy of liver through skin | 21 | $63 | $414 |
| Injection of bile duct for x-ray through already existing skin access using imaging guidance with review by radiologist | 21 | $54 | $386 |
| Ct guidance for tissue removal | 20 | $145 | $773 |
| Destruction of growth of kidney by freezing | 19 | $358 | $1,927 |
| Fluoroscopic guidance for needle placement | 16 | $22 | $111 |
| Core needle biopsy of lung or center cavity of chest (mediastinum), accessed through skin | 15 | $120 | $617 |
| Needle biopsy of growth of abdominal cavity | 15 | $59 | $345 |
| Aspiration of fluid from chest cavity using imaging guidance | 13 | $85 | $452 |
| Insertion of central venous tube with port (5 years or older) | 13 | $258 | $1,432 |
| Needle biopsy of muscle | 12 | $42 | $238 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Appel is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 11% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Appel experienced with fine needle aspiration biopsy using ultrasound guidance, first growth?
Does Dr. Appel receive payments from pharmaceutical companies?
How do Dr. Appel's costs compare to other radiation oncologists in Fort Worth?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology